Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 155Terminated 40Withdrawn 13Unknown 9Recruiting 4Active not recruiting 4Suspended 1No longer available 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma 9Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell 5Leukemia, Lymphocytic, Chronic, B-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Lymphoma, Follicular 4Leukemia, Myeloid, Acute 4Immunoblastic Lymphadenopathy 4Hematologic Neoplasms 4Lymphoma, T-Cell, Peripheral 3Recurrence 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Leukemia 2Hodgkin Disease 2Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Spondylolisthesis 1Spinal Stenosis 1Small Cell Lung Carcinoma 1Sarcoma 1Rectal Neoplasms 1Neurotoxicity Syndromes 1Neoplasms by Histologic Type 1

Interventions

zanubrutinib 1Vincristine 1Rituximab 1Prednisone 1Epirubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Congenital Abnormalities × Lymphoid × Clear all
NCT04668365 2025-04-25

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Henan Cancer Hospital

Phase 2 Suspended
59 enrolled
Lymphoid

Congenital Abnormalities, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡